Skip to main content
Fig. 1 | Journal of Pharmaceutical Policy and Practice

Fig. 1

From: Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020

Fig. 1

Coverage of DTG/ABC/3TC and BIC/FTC/TAF by Region and “Ending the HIV Epidemic” Status, 2020. Coverage of both medications was higher in the Northeast, compared to the Midwest, South and West. Coverage of both medications was lower among QHPs in the West compared to the other regions. A higher proportion of QHPs in EHE jurisdictions covered both medications compared to non-EHE jurisdictions

Back to article page

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us